These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28847668)

  • 1. The discovery and investigation of a crystalline solid solution of an active pharmaceutical ingredient.
    Patel MA; AbouGhaly MHH; Chadwick K
    Int J Pharm; 2017 Oct; 532(1):166-176. PubMed ID: 28847668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzocaine polymorphism: pressure-temperature phase diagram involving forms II and III.
    Gana I; Barrio M; Do B; Tamarit JL; Céolin R; Rietveld IB
    Int J Pharm; 2013 Nov; 456(2):480-8. PubMed ID: 23994015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility of molecular crystals: polymorphism in the light of solubility theory.
    Bennema P; van Eupen J; van der Wolf BM; Los JH; Meekes H
    Int J Pharm; 2008 Mar; 351(1-2):74-91. PubMed ID: 17980982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization of probucol from solution and the glassy state.
    Kawakami K; Ohba C
    Int J Pharm; 2017 Jan; 517(1-2):322-328. PubMed ID: 27979761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermodynamics of the Enantiotropic Pharmaceutical Compound Benzocaine and Solubility in Pure Organic Solvents.
    Cheuk D; Svärd M; Rasmuson ÅC
    J Pharm Sci; 2020 Nov; 109(11):3370-3377. PubMed ID: 32777220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid and Solution State Thermodynamics of Polymorphs of Butamben (Butyl 4-Aminobenzoate) in Pure Organic Solvents.
    Svärd M; Zeng L; Valavi M; Krishna GR; Rasmuson ÅC
    J Pharm Sci; 2019 Jul; 108(7):2377-2382. PubMed ID: 30807760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-state properties and crystallization behavior of PHA-739521 polymorphs.
    Sun CC
    Int J Pharm; 2006 Aug; 319(1-2):114-20. PubMed ID: 16720086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-solid Phase Transitions between Crystalline Polymorphs of Organic Materials.
    Rietveld IB
    Curr Pharm Des; 2023; 29(6):445-461. PubMed ID: 36545715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement.
    Murdande SB; Pikal MJ; Shanker RM; Bogner RH
    Pharm Dev Technol; 2011 Jun; 16(3):187-200. PubMed ID: 20429826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline L-tartrate crystal forms: characterization through crystallography, spectroscopy, and thermodynamics.
    Murphy BJ; Huang J; Casteel MJ; Cobani A; Krzyzaniak JF
    J Pharm Sci; 2010 Jun; 99(6):2766-76. PubMed ID: 20091823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Analysis of the Physicochemical Properties of Benzocaine Polymorphs.
    Paczkowska M; Wiergowska G; Miklaszewski A; Krause A; Mroczkowka M; Zalewski P; Cielecka-Piontek J
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30013003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotigotine: Unexpected Polymorphism with Predictable Overall Monotropic Behavior.
    Rietveld IB; Céolin R
    J Pharm Sci; 2015 Dec; 104(12):4117-4122. PubMed ID: 26343810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure, Solubility and Stability of Orbifloxacin Crystal Forms: Hemihydrate versus Anhydrate.
    Santos OM; Freitas JT; Cazedey EC; de Araújo MB; Doriguetto AC
    Molecules; 2016 Mar; 21(3):328. PubMed ID: 27005603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excipient selection can significantly affect solid-state phase transformation in formulation during wet granulation.
    Airaksinen S; Karjalainen M; Kivikero N; Westermarck S; Shevchenko A; Rantanen J; Yliruusi J
    AAPS PharmSciTech; 2005 Oct; 6(2):E311-22. PubMed ID: 16353990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubility and phase separation of benzocaine and salicylic acid in 1,4-dioxane-water mixtures at several temperatures.
    Peña MA; Bustamante P; Escalera B; Reíllo A; Bosque-Sendra JM
    J Pharm Biomed Anal; 2004 Nov; 36(3):571-8. PubMed ID: 15522532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubility behavior of polymorphs I and II of mefenamic acid in solvent mixtures.
    Romero S; Escalera B; Bustamante P
    Int J Pharm; 1999 Feb; 178(2):193-202. PubMed ID: 10205639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PH-induced nanosegregation of ritonavir to lyotropic liquid crystal of higher solubility than crystalline polymorphs.
    Rodríguez-Spong B; Acciacca A; Fleisher D; Rodríguez-Hornedo N
    Mol Pharm; 2008; 5(6):956-67. PubMed ID: 19434919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solvent influences on metastable polymorph lifetimes: real-time interconversions using energy dispersive X-ray diffractometry.
    DeMatos LL; Williams AC; Booth SW; Petts CR; Taylor DJ; Blagden N
    J Pharm Sci; 2007 May; 96(5):1069-78. PubMed ID: 17455330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.